Heron Therapeutics Inc. (NASDAQ:HRTX) went up by 2.19% during the previous trading session, and it is maintaining the win ahead of Monday’s trading session. The share price of the Biotechnology giant went up by $19.16 to trade ended Monday trading at $18.75. This is up from the $18.75 price recorded on Friday’s trading session. Thanks to this latest performance, HRTX is closer to the higher price 52-week target of $70.00 and further from the lowest price target of $24.00. Its performance from the start of the year has also been negative, with HRTX down by -18.47% year-to-date.
Heron Therapeutics Inc. (HRTX) started the day trading at $18.39 and recorded an intraday high of $19.77. It also recorded an intraday low of $18.11 during Monday’s trading session. Heron Therapeutics Inc. is a very active stock that recorded a trading volume that is less than -18.7% of the average daily trading volume on Monday. The stock’s trading volume on Monday was 985688, which is less than -18.7 of the total average daily trading volume of 1.17 million.
Heron Therapeutics Inc. (NASDAQ:HRTX) 2020 Performance Impressive
The increase in HRTX’s stock price on Monday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of HRTX currently stands at $26.81, which is higher than the current trading price of the stock by 28.53%. However, HRTX’s current trading price is -99.58% lower than the 52-week low price of $9.60. In terms of trading volume, Heron Therapeutics Inc. currently experienced healthy participation during the last trading session. 985688 shares of Heron Therapeutics Inc. were traded on the stock exchange on Monday, which is less than -18.7% of the 1.17 million average trading volume of the stock.
The performance of the stock has been positive over the past year. HRTX’s performance over the past one year has seen it surge by 8.56%, while the stock has gone down by -25.04% in the last six months. The quarterly performance of HRTX currently stands at 81.78%, and it is up by 32.87% in the last month. The only negative figure was from the weekly performance, which currently reads -4.18%. At the time of writing HRTX’s report, the company has a total market cap of $1.69B, making it one of the largest publicly-traded companies in the world.Heron Therapeutics Inc. also has over 231 employees all over the world.
HRTX Insider Activities
The insider transactions over the past six months are down by -113.00%.For Heron Therapeutics Inc. insiders bought 1,158 shares in 1 transactions. In that same period, insiders sold 7,742 of their shares in 2 transactions. After these transactions, insiders at Heron Therapeutics Inc. now hold 117.83k shares, which is over 108.75% of the total company stocks. Institutional investors currently hold a large chunk of the HRTX shares, as they control 0.13% of the company’s total stock.
HRTX Fundamental Analysis
For Heron Therapeutics Inc., the stock’s diluted earnings per share (EPS) stands at -2.27. In the coming year, analysts expect the EPS to be -1.19. The EPS growth will up over the next five years to 47.50% after surging by 2.70% in the previous five years. In terms of revenue, Heron Therapeutics Inc.’s quarterly sales (YOY) is shrinking at -0.65, which is lower than the average annual revenue of 2.70% over the past half a decade.
The Return on Investment (ROI) on Heron Therapeutics Inc.’s stock currently stands at -51.50%. The gross margin of the company is 60.20%.
HRTX Analysts Prediction
The Needham also has a Buy rating for Heron Therapeutics Inc., predicting the stock price to stay between $50 and $48. Another analyst that has a Buy rating for HRTX is Needham, which set a price target of between $66 and $64. and Mizuho reiterate their Buy position on the stock ($28 and $35).
Analysts at Needham believe that HRTX is Buy, and they have a price target of between $28 and $30. Mizuho and Needham also believe that Heron Therapeutics Inc.’s stock is outperforming at the moment.
At the moment, Heron Therapeutics Inc.’s Total Debt to Equity ratio stands at 0.02, and they have a long-term Debt to Equity ratio of 0.00.
HRTX Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of HRTX currently stands at 5.54%, while the SMA50 is 20.79%. The biggest one is the SMA200, which is currently reading 0.04% ahead of Monday’s trading session. The Relative Strength Index of this stock is 60.87.